SMMT Summit Therapeutics PLC

USD 4.14 0.39 10.4
Icon

Summit Therapeutics PLC (SMMT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.14

+0.39 (+10.40)%

USD 2.36B

4.68M

USD 8.00(+93.24%)

N/A

Icon

SMMT

Summit Therapeutics PLC (USD)
COMMON STOCK | NSD
USD 4.14
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.36B

N/A

USD 4.14

Summit Therapeutics PLC (SMMT) Stock Forecast

Show ratings and price targets of :
USD 8.00
(+93.24%)

Based on the Summit Therapeutics PLC stock forecast from 1 analysts, the average analyst target price for Summit Therapeutics PLC is USD 8.00 over the next 12 months. Summit Therapeutics PLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Summit Therapeutics PLC is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, Summit Therapeutics PLC’s stock price was USD 4.14. Summit Therapeutics PLC’s stock price has changed by +16.62% over the past week, -8.61% over the past month and +136.57% over the last year.

No recent analyst target price found for Summit Therapeutics PLC
No recent average analyst rating found for Summit Therapeutics PLC

Company Overview Summit Therapeutics PLC

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Iv...Read More

https://www.summittxinc.com

601 Brickell Key Drive, Miami, FL, United States, 33131

105

January

USD

USA

Adjusted Closing Price for Summit Therapeutics PLC (SMMT)

Loading...

Unadjusted Closing Price for Summit Therapeutics PLC (SMMT)

Loading...

Share Trading Volume for Summit Therapeutics PLC Shares

Loading...

Compare Performance of Summit Therapeutics PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SMMT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Summit Therapeutics PLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing SMMT

Symbol Name SMMT's Weight Expense Ratio Price(Change) Market Cap
SBIO
ALPS Medical Breakthrough.. 2.43 % 0.50 % +0.15 (+0.42%) USD0.11B

Frequently Asked Questions About Summit Therapeutics PLC (SMMT) Stock

Based on ratings from 1 analysts Summit Therapeutics PLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on SMMT's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for SMMT is USD 8.00 over the next 12 months. The maximum analyst target price is USD 8 while the minimum anlayst target price is USD 8.

SMMT stock's Price/Earning ratio is 1.99. Our analysis grades SMMT stock's Price / Earning ratio at D. This means that SMMT stock's Price/Earning ratio is above 35% of the stocks in the Biotechnology sector in the NSD exchange. Based on this SMMT may be fairly valued for its sector

The last closing price of SMMT's stock was USD 4.14.

The most recent market capitalization for SMMT is USD 2.36B.

Based on targets from 1 analysts, the average taret price for SMMT is projected at USD 8.00 over the next 12 months. This means that SMMT's stock price may go up by +93.24% over the next 12 months.

Following are ETFs with the highest allocation to Summit Therapeutics PLC's stock :

SBIO

As per our most recent records Summit Therapeutics PLC has 105 Employees.

Summit Therapeutics PLC's registered address is 601 Brickell Key Drive, Miami, FL, United States, 33131. You can get more information about it from Summit Therapeutics PLC's website at https://www.summittxinc.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...